![Brent Pfeiffenberger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brent Pfeiffenberger
Vorstandsvorsitzender bei
CENTURY THERAPEUTICS, INC.
Vermögen: 9 Mio $ am 31.05.2026
Profil
Brent Pfeiffenberger is currently Chairman, President & Chief Executive Officer at Century Therapeutics, Inc. starting in 2025 and Independent Director at Corbus Pharmaceuticals Holdings, Inc. starting in 2026.
Former roles include Chief Operating Officer at Neogene Therapeutics, Inc. from 2021 to 2023 and Director at Medicines Australia.
Education includes an MBA from The Wharton School of the University of Pennsylvania and a doctorate from Duquesne University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.06.2026 | 3’665’474 ( 2.03% ) | 9 Mio $ | 31.05.2026 |
Aktive Positionen von Brent Pfeiffenberger
| Unternehmen | Position | Beginn |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Vorstandsvorsitzender | 04.12.2023 |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 13.05.2026 |
Ehemalige bekannte Positionen von Brent Pfeiffenberger
| Unternehmen | Position | Ende |
|---|---|---|
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers | Geschäftsführer | 01.12.2023 |
Medicines Australia
 Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Direktor/Vorstandsmitglied | - |
Ausbildung von Brent Pfeiffenberger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Neogene Therapeutics, Inc.
Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
